Virtue Diagnostics
PrivateLast Round
Series B
Jan 6, 2022
Total Funding Raised
$130.6M
Company Overview
Virtue Diagnostics operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series B round in January 2022.
Virtue Diagnostics is an innovative in vitro diagnostics (IVD) company that develops and manufactures diagnostic solutions for infectious diseases, cancer, maternal and fetal health, and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virtue Diagnostics Comparables
Compare Virtue Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Maccura Biotechnology Co Ltd | 75% | |
| Shenzhen New Industries Biomedical Engineering | 74% | |
| Autobio Diagnostics Co Ltd | 74% |
For institutional investors. Book with your work email.
Virtue Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 6, 2022 | ||||
| Series A | Dec 18, 2020 |
For institutional investors. Book with your work email.
Virtue Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series B |
| Morningside Ventures | Series B |
| Lilly Asia Ventures | Series B, Series A |
| Lilly Asia Ventures | Series B, Series A |
| HongShan Capital Group (HSG) | Series B |
Recent news
Latest coverage and updates
- expands_facilitiesSep 3, 2026
Virtuedx expands its physical manufacturing footprint in Indonesia with a modern 12,200-square-meter facility, inaugurated in 2024, that produces more than 1,000 diagnostic instruments annually and 6,000 liters of reagents daily.
For institutional investors. Book with your work email.
Virtue Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Virtue Diagnostics's valuation, stock price, and market status.
Is Virtue Diagnostics a public or private company?
Virtue Diagnostics is a private company.
What is the current stock price of Virtue Diagnostics?
Virtue Diagnostics is a private company, so its shares have no public market price. Caplight tracks Virtue Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Virtue Diagnostics worth (valuation)?
Valuation information for Virtue Diagnostics is not publicly available.
Can I buy Virtue Diagnostics stock?
Virtue Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Virtue Diagnostics's last funding round?
Virtue Diagnostics's most recent funding round was Series B on January 6, 2022.
Who are the main investors in Virtue Diagnostics?
Key investors in Virtue Diagnostics include Oriza Holdings, Morningside Ventures, Lilly Asia Ventures, Lilly Asia Ventures, HongShan Capital Group (HSG).
Will Virtue Diagnostics IPO soon?
No public IPO plans have been announced for Virtue Diagnostics.
How can I track Virtue Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Virtue Diagnostics's shares on secondary markets.